Literature DB >> 12383191

Resolution of skeletal muscle inflammation in mdx dystrophic mouse is accompanied by increased immunoglobulin and interferon-gamma production.

Jussara Lagrota-Candido1, Rita Vasconcellos, Marta Cavalcanti, Marcelo Bozza, Wilson Savino, Thereza Quirico-Santos.   

Abstract

Mdx mouse, the animal model of Duchenne muscular dystrophy, develops an X-linked recessive inflammatory myopathy with an apparent sustained capacity for muscle regeneration. We analysed whether changes in the skeletal muscle during myonecrosis and regeneration would correlate with functional alterations in peripheral lymphoid tissues. Here we show that during the height of myonecrosis, mdx mice display marked atrophy of peripheral lymph nodes and extensive muscle inflammation. In contrast, enlargement of draining lymph nodes with accumulation of CD4+ CD44+, CD4+ CD25+, CD8+ CD44+ T lymphocytes and type-2 B cells was consistently observed during amelioration of the muscle lesion. In addition, regeneration of the muscular tissue was accompanied by concomitant increase of immunoglobulin-secreting cells in regional lymph nodes and bone marrow. Double immunolabelling analysis revealed intense B cell proliferation and formation of germinal centre in the follicles of dystrophic regional lymph nodes. Furthermore, lymph node cells produced large amounts of IFN-gamma but not IL-4, IL-6 or IL-10 after in vitro mitogen stimulation with Concanavalin A. As these alterations occurred mainly during the recovery period, we suggested that local activation of the immune system could be an influence which mitigates the myonecrosis of muscular tissue in the mdx dystrophic mouse.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12383191      PMCID: PMC2517677          DOI: 10.1046/j.1365-2613.2002.00221.x

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  38 in total

1.  Negative selection of multireactive B cell clones in normal adult mice.

Authors:  A Grandien; R Fucs; A Nobrega; J Andersson; A Coutinho
Journal:  Eur J Immunol       Date:  1994-06       Impact factor: 5.532

Review 2.  Interferon-gamma: biology and role in pathogenesis.

Authors:  A Billiau
Journal:  Adv Immunol       Date:  1996       Impact factor: 3.543

3.  Extracellular matrix components of the mouse thymus microenvironment. V. Interferon-gamma modulates thymic epithelial cell/thymocyte interactions via extracellular matrix ligands and receptors.

Authors:  J M Lagrota-Cândido; D M Villa-Verde; F H Vanderlei; W Savino
Journal:  Cell Immunol       Date:  1996-06-15       Impact factor: 4.868

4.  Site-dependent pathological differences in smooth muscles and skeletal muscles of the adult mdx mouse.

Authors:  B Boland; B Himpens; J F Denef; J M Gillis
Journal:  Muscle Nerve       Date:  1995-06       Impact factor: 3.217

5.  The molecular basis of muscular dystrophy in the mdx mouse: a point mutation.

Authors:  P Sicinski; Y Geng; A S Ryder-Cook; E A Barnard; M G Darlison; P J Barnard
Journal:  Science       Date:  1989-06-30       Impact factor: 47.728

6.  Constitutive and cytokine-induced expression of human leukocyte antigens and cell adhesion molecules by human myotubes.

Authors:  D Michaelis; N Goebels; R Hohlfeld
Journal:  Am J Pathol       Date:  1993-10       Impact factor: 4.307

7.  Nature of the mononuclear infiltrate and the mechanism of muscle damage in juvenile dermatomyositis and Duchenne muscular dystrophy.

Authors:  R M McDouall; M J Dunn; V Dubowitz
Journal:  J Neurol Sci       Date:  1990-11       Impact factor: 3.181

8.  mdx mice show progressive weakness and muscle deterioration with age.

Authors:  C Pastoret; A Sebille
Journal:  J Neurol Sci       Date:  1995-04       Impact factor: 3.181

9.  Increased deposition of extracellular matrix components in the thymus gland of MDX mouse: correlation with the muscular lesion.

Authors:  T Quirico-Santos; M M Ribeiro; W Savino
Journal:  J Neuroimmunol       Date:  1995-06       Impact factor: 3.478

10.  Expression of transforming growth factor-beta 1 in dystrophic patient muscles correlates with fibrosis. Pathogenetic role of a fibrogenic cytokine.

Authors:  P Bernasconi; E Torchiana; P Confalonieri; R Brugnoni; R Barresi; M Mora; F Cornelio; L Morandi; R Mantegazza
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

View more
  12 in total

1.  Extraocular muscle satellite cells are high performance myo-engines retaining efficient regenerative capacity in dystrophin deficiency.

Authors:  Pascal Stuelsatz; Andrew Shearer; Yunfei Li; Lindsey A Muir; Nicholas Ieronimakis; Qingwu W Shen; Irina Kirillova; Zipora Yablonka-Reuveni
Journal:  Dev Biol       Date:  2014-09-16       Impact factor: 3.582

2.  Interferon-γ resets muscle cell fate by stimulating the sequential recruitment of JARID2 and PRC2 to promoters to repress myogenesis.

Authors:  Priya Londhe; Judith K Davie
Journal:  Sci Signal       Date:  2013-12-10       Impact factor: 8.192

3.  Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy.

Authors:  S Armando Villalta; Hal X Nguyen; Bo Deng; Tomomi Gotoh; James G Tidball
Journal:  Hum Mol Genet       Date:  2008-11-07       Impact factor: 6.150

4.  Gender dimorphism influences extracellular matrix expression and regeneration of muscular tissue in mdx dystrophic mice.

Authors:  Maria Cristina Salimena; Jussara Lagrota-Candido; Thereza Quírico-Santos
Journal:  Histochem Cell Biol       Date:  2004-09-28       Impact factor: 4.304

5.  Fast skeletal myofibers of mdx mouse, model of Duchenne muscular dystrophy, express connexin hemichannels that lead to apoptosis.

Authors:  Luis A Cea; Carlos Puebla; Bruno A Cisterna; Rosalba Escamilla; Aníbal A Vargas; Marina Frank; Paloma Martínez-Montero; Carmen Prior; Jesús Molano; Isabel Esteban-Rodríguez; Ignacio Pascual; Pía Gallano; Gustavo Lorenzo; Héctor Pian; Luis C Barrio; Klaus Willecke; Juan C Sáez
Journal:  Cell Mol Life Sci       Date:  2016-01-23       Impact factor: 9.261

Review 6.  Inflammation induced loss of skeletal muscle.

Authors:  Priya Londhe; Denis C Guttridge
Journal:  Bone       Date:  2015-11       Impact factor: 4.398

7.  Novel approach to meta-analysis of microarray datasets reveals muscle remodeling-related drug targets and biomarkers in Duchenne muscular dystrophy.

Authors:  Ekaterina Kotelnikova; Maria A Shkrob; Mikhail A Pyatnitskiy; Alessandra Ferlini; Nikolai Daraselia
Journal:  PLoS Comput Biol       Date:  2012-02-02       Impact factor: 4.475

8.  Treatment with soluble activin type IIB-receptor improves bone mass and strength in a mouse model of Duchenne muscular dystrophy.

Authors:  Tero Puolakkainen; Hongqian Ma; Heikki Kainulainen; Arja Pasternack; Timo Rantalainen; Olli Ritvos; Kristiina Heikinheimo; Juha J Hulmi; Riku Kiviranta
Journal:  BMC Musculoskelet Disord       Date:  2017-01-19       Impact factor: 2.362

Review 9.  Mechanisms Regulating Muscle Regeneration: Insights into the Interrelated and Time-Dependent Phases of Tissue Healing.

Authors:  Laura Forcina; Marianna Cosentino; Antonio Musarò
Journal:  Cells       Date:  2020-05-22       Impact factor: 6.600

10.  Granulocyte-colony stimulating factor improves MDX mouse response to peripheral nerve injury.

Authors:  Gustavo Ferreira Simões; Alexandre Leite Rodrigues de Oliveira
Journal:  PLoS One       Date:  2012-08-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.